Glyconics Ltd

Glyconics is a company at the forefront of diagnostic innovation, using infrared spectroscopy to analyse samples for markers of disease across a wide range of conditions.

4 million people globally will end up in hospital at a cost of £14bn. Using Infrared spectroscopy, our hand-held device can diagnose and predict days before when such acute attack will happen so saving time, money and lives. Our platform can be used for a wide range of acute and chronic conditions.

Glyconics are in the Business Weekly Top 50 Cambridge companies to watch and won EU awards and UK grants.

Stay up to date with Glyconics Ltd

Login or create a free user account to follow this company and see updates on your dashboard.

Create account